Feasibility of cohort event monitoring and assessment of reactogenicity and adverse events among a cohort of AstraZeneca and Moderna COVID-19 vaccine recipients in Nigeria, 2021
2025VaccineJournalOpen access
10.1016/j.vaccine.2025.126907Full text2 citations